Literature DB >> 20143070

Changes in quality of life after lung surgery in old and young patients: are they similar?

Axel Möller1, Ulrik Sartipy.   

Abstract

BACKGROUND: The aim of the study was to compare the changes in health-related quality of life (QOL) after lung surgery between young and old patients.
METHODS: We performed a prospective, population-based, cohort study to investigate health-related QOL before and 6 months after lung surgery. We used the validated instrument Short Form-36 (SF-36), to investigate QOL. The main outcome measures were fractional change in the SF-36 physical (DeltaPCS%) and mental (DeltaMCS%) component summary scores. We also compared the two age groups to age- and sex-matched reference populations.
RESULTS: We included 249 patients: 166 young (<70 years) and 83 old (> or =70 years) patients. The overall response rate at 6 months was 84%. There was no significant difference in the primary outcome measures between young and old patients (DeltaPCS% -13 vs. -16, p = 0.55; DeltaMCS% 9 vs. 1, p = 0.22). The 2-year survivals (mean follow-up 2.1 years) were 83% and 84% in young and old patients, respectively (p = 0.72). In both groups, physical and mental QOL were lower than in the reference populations.
CONCLUSIONS: We found that at 6 months after lung surgery old patients experienced deterioration in physical and mental health-related QOL similar to that of young patients. Survival also was similar in the two groups.

Entities:  

Mesh:

Year:  2010        PMID: 20143070     DOI: 10.1007/s00268-010-0430-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Quality of life in the elderly after major lung resection for lung cancer.

Authors:  Michele Salati; Alessandro Brunelli; Francesco Xiumè; Majed Refai; Armando Sabbatini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-10-20

2.  Quality of life outcomes are equivalent after lobectomy in the elderly.

Authors:  William R Burfeind; Betty C Tong; Erin O'Branski; James E Herndon; Eric M Toloza; Thomas A D'Amico; Linda H Harpole; David H Harpole
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09       Impact factor: 5.209

3.  Patient preferences regarding possible outcomes of lung resection: what outcomes should preoperative evaluations target?

Authors:  S Cykert; G Kissling; C J Hansen
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

4.  Cancer statistics, 2000.

Authors:  R T Greenlee; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  2000 Jan-Feb       Impact factor: 508.702

5.  The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden.

Authors:  M Sullivan; J Karlsson; J E Ware
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

6.  Results of pulmonary resection for lung cancer in Norway, patients older than 70 years.

Authors:  Hans Rostad; Anne Naalsund; Trond-Eirik Strand; Randi Jacobsen; Olaug Talleraas; Jarle Norstein
Journal:  Eur J Cardiothorac Surg       Date:  2005-02       Impact factor: 4.191

7.  Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.

Authors:  Boone Goodgame; Avinash Viswanathan; Jennifer Zoole; Feng Gao; C Ryan Miller; Janakiraman Subramanian; Bryan F Meyers; Alexander G Patterson; Ramaswamy Govindan
Journal:  J Thorac Oncol       Date:  2009-11       Impact factor: 15.609

8.  Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer.

Authors:  William D Bolton; David C Rice; Arlene M Correa; Wayne Hofstetter; Ritsuko Komaki; Reza Mehran; Katherine Pisters; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Stephen G Swisher
Journal:  Am Surg       Date:  2009-07       Impact factor: 0.688

9.  Age-related impairment of quality of life after lung resection for non-small cell lung cancer.

Authors:  Tobias Schulte; Bodo Schniewind; Jessica Walter; Peter Dohrmann; Thomas Küchler; Roland Kurdow
Journal:  Lung Cancer       Date:  2009-07-08       Impact factor: 5.705

10.  Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.

Authors:  Patricia M Kenny; Madeleine T King; Rosalie C Viney; Michael J Boyer; Christine A Pollicino; Jocelyn M McLean; Michael J Fulham; Brian C McCaughan
Journal:  J Clin Oncol       Date:  2007-12-17       Impact factor: 44.544

View more
  4 in total

Review 1.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Impact on quality of life after vagus nerve and phrenic nerve guided systematic nodal dissection for non-small cell lung cancer patients: a prospective, single-arm clinical trial.

Authors:  Yao Liu; Weixiong Yang; Jiali Yang; Shufen Liao; Zhenguo Liu; Bo Zeng; Chao Cheng
Journal:  Ann Transl Med       Date:  2021-12

Review 3.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

4.  Patient features predicting long-term survival and health-related quality of life after radical surgery for non-small cell lung cancer.

Authors:  Ville Rauma; Jarmo Salo; Harri Sintonen; Jari Räsänen; Ilkka Ilonen
Journal:  Thorac Cancer       Date:  2016-01-21       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.